Skip to main content
OpenTrials
Completed

NCT Number: NCT02750072

INfrapatellar Versus SUprapatellar Reamed Intramedullary Nailing for Fractures of the Tibia

This study will investigate the incidence and severity of anterior knee pain comparing two different approaches to tibial nail fixation; Infrapatellar versus percutaneous semi-extended suprapatellar incisions. Half the patients will be randomized to the gold standard infrapatellar approach with the other half being randomized to treatment with the percutaneous semi-extended suprapatellar approach.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Alberta Hospital, Edmonton, Alberta, Canada

Loading trial locations.

About this study

There are a number of ways to approach the tibial canal when using an intramedullary nail for fracture fixation.

The gold standard is the infrapatellar approach (below the knee cap). This approach has the patient positioned with the knee flexed at 90 degrees or greater on the operating table. However, there are challenges with this approach, including imaging, placement of supplemental fixation, conversion to open reduction when necessary and malunion with apex anterior angulation for proximal tibial fractures. The positioning of the patient causes tension on the structures and soft tissues around the knee which can hinder the placement of the nail and can cause damage to the soft tissues that can result in significant long-term anterior knee pain for many patients.

The semi-extended suprapatellar approach has the patient positioned in approximately 15-20 degrees of flexion, putting less tension on the structures and soft tissues about the knee and enables the surgeon to insert the nail in an optimal position with relative ease.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all extra-articular tibial fractures
  • simple distal tibial intra-articular fractures amenable to IMN
  • open and closed fractures
  • bilateral tibiae
  • willing and able to consent, follow protocol and attend follow-up visits
  • able to read and understand English or have interpreter available

Exclusion criteria

  • patients with contralateral femur and/or hip fracture requiring retrograde IMN
  • patients with contralateral knee injuries that would impair their ability to kneel during the follow-up period
  • associated knee injury
  • previous symptomatic knee pathology
  • ipsilateral injuries to the same limb that would interfere with rehab or outcome
  • neurovascular injuries at the level of the knee requiring surgery
  • open or closed fractures > 14 days (times of injury to OR)
  • non unions
  • pathologic fractures
  • periprosthetic fractures
  • spinal injury
  • non-ambulatory patients
  • incarceration
  • limited life expectancy due to significant medical co-morbidities or medical contra-indication to surgery (pregnancy)
  • likely problems, in the judgment of the investigators, with maintaining follow-up

Treatment and study plan

Infrapatellar Approach

Procedure

Infrapatellar approach using the surgeon's incision of choice (i.e. patellar tendon split, tendon retraction medial, tendon retraction lateral)

Suprapatellar Approach

Procedure

Semi-extended suprapatellar approach using quadriceps split combined with purpose designed percutaneous instrumentation

Primary outcomes

  1. VAS (visual analog scale) for pain on kneeling/ability to knee

    Time frame: 12 months post treatment

    Participants assessment of their degree/level of pain on kneeling after performing the AKT (Aberdeen Kneeling Weight-Distribution Test) on a 10 cm visual analog scale

Secondary outcomes

  1. AKT (Aberdeen Kneeling Weight-Distribution Test)

    Time frame: 4, 6, 12 and 24 months post treatment

    The AKT involves kneeling on two separate calibrated scales for up to 60 seconds with the patient blinded to the readings. At 15-second intervals the weight distribution, measured in kg, between the two knees is documented.

  2. AST (Aberdeen Standing Weight-Distribution Test)

    Time frame: 4, 6, 12 and 24 months post treatment

    The AST involves the patient standing on two separate calibrated scales (one foot on each scale) and the weight in kg recorded with the patient blinded to the readings.

  3. VAS (Visual Analog Scale) at rest, with walking and descending stairs

    Time frame: 4, 6, 12 and 24 months post treatment

    Participants overall assessment of their pain at rest, with walking and descending stairs over the past week on a 10 cm visual analog scale

  4. Lysholm Knee Scoring Scale

    Time frame: 4, 6, 12 and 24 months post treatment

    Used to evaluate outcomes of knee ligament surgery using 8-items commonly affecting patients with anterior knee pain: Limp, support, locking, instability, pain, swelling, stair climbing and squatting.

  5. PKPM (Photographic knee pain map)

    Time frame: 4, 6,12 and 24 months post treatment

    Used to determine the precise location of the knee pain, as indicated and localized by the participant.

  6. EQ-5D Health Related Quality of Life Outcome Measure

    Time frame: 4, 6,12 and 24 months post treatment

    5 dimensions: Mobility: self-care, usual activities, pain/discomfort and anxiety/depression

  7. WPAI:SHP (Work Productivity and Activity Impairment: Specific Health Problem

    Time frame: 4, 6, 12 and 24 months post treatment

    A questionnaire pertaining to the effect of the participants tibial fracture on their ability to work and perform regular activities.

  8. Radiographic outcome

    Time frame: Intra-operatively and 4, 6,12 and 24 months post treatment

    Blinded independent reviewer will adjudicate alignment, nail position and determination of union at one year, as well as change of position of the nail.

Sponsors and collaborators

Lead sponsor

Fraser Orthopaedic Research Society

Network

Registry information

Acronym: INSURT

Important dates

Study start
2016
Primary completion
2023
Study completion
2023
First posted
Apr 25, 2016
Registry last updated
Jan 30, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.